July 28 -- Our latest BWest series: Bioengineering the Senses. We take a closer look at tech on the frontiers of medical science. Today, we take a look at organs-on-a-chip under development at the Wyss Institute of Harvard University. Could this device speed up and improve the way new medicines are developed?
Terrafugia is excited to premier the new Outer Mold Line for the TF-X™, Terrafugia's vision for the future of personal transportation. The TF-X™ will be a four-seat, vertical takeoff and landing (VTOL) hybrid electric aircraft that makes flying easier and safer than ever before. Visit terrafugia.com for more information.
July 27 -- Thomas Price, an analyst at Morgan Stanley, talks about the outlook for gold and other commodities. He speaks with Pimm Fox and Olivia Sterns on Bloomberg Television's "Bloomberg Markets."
July 24 -- What’s good for patients is also good for business. The painkiller market alone is worth $18 billion a year. The drug industry is pressing ahead with research into genetic irregularities. The FDA is expected to approve a cholesterol-lowering treatment from Sanofi and Regeneron Pharmaceuticals based on the rare gene mutation of an aerobics instructor with astoundingly low cholesterol levels. Bloomberg's Caroline Chen has more on "Bloomberg Markets."